News

Treating cancer is becoming increasingly complex, but also offers more and more possibilities. After all, the better a tumor’s biology and genetic features are understood, the more treatment approaches there are.

Research shows that some lung cancer cells retain a “memory” of the healthy cell where they came from — one that might be exploited to make an emerging type of lung cancer treatment called KRAS inhibition more effective.

The research analyzed risk for the disease across more than 30,000 Mexican Americans, finding third-generation Mexican Americans 66% more likely to get liver cancer than the first generation.

ETH Zurich researchers are illuminating what can happen when cells exceed their normal size and become senescent. Their new findings could help to optimise cancer treatments.

A new study has identified an antibody that can supercharge the immune system, helping to overcome a previously unknown mechanism by which cancer cells prevent phagocytosis.

A promising new cancer therapy also appears extremely potent against one of the world’s most devastating infectious diseases: tuberculosis (TB). Scientists found the therapy dramatically reduces TB growth, even for bacteria that are drug-resistant.

A genomic tug of war for a gene activator could explain why some cancers respond to decitabine and others don't respond or become resistant over time.

A lesser-known DNA repair pathway that is upregulated in breast, ovarian and prostate cancer has been pieced together and laid out step by step in a new paper.

Macrophages, a type of white blood cell that can destroy invading pathogens, have an innate ability to infiltrate tumor cells, making them a potentially important tool in treatments that use transplanted cells to fight disease, known as cell therapy.

Researchers have identified the genetic changes that occur during pancreatic cancer metastasis and have found a drug to disrupt the process.